RESUMO
Patients with intestinal fat malabsorption and urolithiasis are particularly at risk of acquiring fat-soluble vitamin deficiencies. The aim of the study was to evaluate the vitamin status and metabolic profile before and after the supplementation of fat-soluble vitamins A, D, E and K (ADEK) in 51 patients with fat malabsorption due to different intestinal diseases both with and without urolithiasis. Anthropometric, clinical, blood and 24-h urinary parameters and dietary intake were assessed at baseline and after ADEK supplementation for two weeks. At baseline, serum aspartate aminotransferase (AST) activity was higher in stone formers (SF; n = 10) than in non-stone formers (NSF; n = 41) but decreased significantly in SF patients after supplementation. Plasma vitamin D and E concentrations increased significantly and to a similar extent in both groups during intervention. While plasma vitamin D concentrations did not differ between the groups, vitamin E concentrations were significantly lower in the SF group than the NSF group before and after ADEK supplementation. Although vitamin D concentration increased significantly in both groups, urinary calcium excretion was not affected by ADEK supplementation. The decline in plasma AST activity in patients with urolithiasis might be attributed to the supplementation of ADEK. Patients with fat malabsorption may benefit from the supplementation of fat-soluble vitamins ADEK.
Assuntos
Síndromes de Malabsorção/sangue , Urolitíase/sangue , Vitamina A/sangue , Vitamina D/sangue , Vitamina E/sangue , Vitamina K/sangue , Adulto , Idoso , Aspartato Aminotransferases/sangue , Colesterol/sangue , Suplementos Nutricionais , Feminino , Humanos , Síndromes de Malabsorção/complicações , Síndromes de Malabsorção/terapia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Triglicerídeos/sangue , Urolitíase/complicações , Urolitíase/terapia , Vitamina A/administração & dosagem , Deficiência de Vitamina A/sangue , Deficiência de Vitamina A/etiologia , Deficiência de Vitamina A/terapia , Vitamina D/administração & dosagem , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/etiologia , Deficiência de Vitamina D/terapia , Vitamina E/administração & dosagem , Deficiência de Vitamina E/sangue , Deficiência de Vitamina E/etiologia , Deficiência de Vitamina E/terapia , Vitamina K/administração & dosagem , Deficiência de Vitamina K/sangue , Deficiência de Vitamina K/etiologia , Deficiência de Vitamina K/terapia , Vitaminas/administração & dosagem , Vitaminas/sangueRESUMO
BACKGROUND: Home parenteral nutrition (HPN) is a life-preserving therapy for patients with chronic intestinal failure (CIF) indicated for patients who cannot achieve their nutritional requirements by enteral intake. Intravenously administered lipid emulsions (ILEs) are an essential component of HPN, providing energy and essential fatty acids, but can become a risk factor for intestinal-failure-associated liver disease (IFALD). In HPN patients, major effort is taken in the prevention of IFALD. Novel ILEs containing a proportion of omega-3 polyunsaturated fatty acids (n-3 PUFA) could be of benefit, but the data on the use of n-3 PUFA in HPN patients are still limited. METHODS/DESIGN: The HOME study is a prospective, randomized, controlled, double-blind, multicenter, international clinical trial conducted in European hospitals that treat HPN patients. A total of 160 patients (80 per group) will be randomly assigned to receive the n-3 PUFA-enriched medium/long-chain triglyceride (MCT/LCT) ILE (Lipidem/Lipoplus® 200 mg/ml, B. Braun Melsungen AG) or the MCT/LCT ILE (Lipofundin® MCT/LCT/Medialipide® 20%, B. Braun Melsungen AG) for a projected period of 8 weeks. The primary endpoint is the combined change of liver function parameters (total bilirubin, aspartate transaminase and alanine transaminase) from baseline to final visit. Secondary objectives are the further evaluation of the safety and tolerability as well as the efficacy of the ILEs. DISCUSSION: Currently, there are only very few randomized controlled trials (RCTs) investigating the use of ILEs in HPN, and there are very few data at all on the use of n-3 PUFAs. The working hypothesis is that n-3 PUFA-enriched ILE is safe and well-tolerated especially with regard to liver function in patients requiring HPN. The expected outcome is to provide reliable data to support this thesis thanks to a considerable number of CIF patients, consequently to broaden the present evidence on the use of ILEs in HPN. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03282955. Registered on 14 September 2017.
Assuntos
Emulsões Gordurosas Intravenosas/uso terapêutico , Ácidos Graxos Ômega-3/administração & dosagem , Síndromes de Malabsorção/terapia , Nutrição Parenteral no Domicílio/métodos , Fosfolipídeos/uso terapêutico , Sorbitol/uso terapêutico , Triglicerídeos/administração & dosagem , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Bilirrubina/sangue , Método Duplo-Cego , Combinação de Medicamentos , Emulsões Gordurosas Intravenosas/efeitos adversos , Feminino , Humanos , Testes de Função Hepática/métodos , Síndromes de Malabsorção/sangue , Masculino , Pessoa de Meia-Idade , Fosfolipídeos/efeitos adversos , Estudos Prospectivos , Sorbitol/efeitos adversos , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) reduces obesity-related co-morbidities, such as diabetes, hypertension, and hyperlipidemia. Endocrinological abnormalities may occur as undesired side effects. Most centers routinely prescribe folic acid, cyanocobalamin (vitB12), and protein replacement in the postoperative period, but 25-OH-vitamin-D3 (vitD) and intact parathyroid hormone (iPTH) levels are not routinely followed up. The aim of this study was to identify the effects of LSG on iPTH, vitD, calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), and albumin levels. METHODS: Data of morbidly obese patients who underwent LSG between January and December 2014 were studied in this prospectively designed study. Serum levels of iPTH, vitD, Ca, P, folic acid, vitB12, ALP, and albumin were measured preoperatively and postoperatively at the 3rd, 6th, and 12th months. RESULTS: In total, 119 patients were analyzed. All patients had normal iPTH, vitD, Ca, P, folic acid, vitB12, ALP, and albumin values preoperatively, and 31.6% had received vitD supplementation during their nutritionist observation time before surgery. At the 3rd, 6th, and 12th postoperative months, 21 (17.6%), 17 (17.3%), and 1 (0.8%) patients, respectively, had increased iPTH and ALP and decreased vitD levels. A total of 39 (32.7%) patients needed high-dose vitD treatment during a 1 year follow-up. Approximately 37.5% of the patients who received vitD supplementation preoperatively needed vitD supplementation postoperatively. Hospital records of 101 of 119 patients who underwent LSG could be screened to determine their vitD supplementation requirements previously ordered by their nutritionist for a 1-year period before LSG. Thirty-two (31.6%) of the 101 patients had received vitD supplementation during the 1-year period preoperatively. CONCLUSIONS: Although serum levels of iPTH, vitD, Ca, P, vitB12, ALP, and albumin may be normal preoperatively, severe vitD insufficiency requiring high-dose vitD replacement may develop in morbidly obese patients postoperatively. Instead of iPTH and vitD, which are expensive to measure, ALP serum level, which is correlated with iPTH levels, can be a good indicator to monitor calcium metabolism.
Assuntos
Albuminas/metabolismo , Cálcio/sangue , Gastrectomia , Obesidade Mórbida/cirurgia , Hormônio Paratireóideo/sangue , Fósforo/sangue , Vitamina D/sangue , Adolescente , Adulto , Idoso , Suplementos Nutricionais , Feminino , Gastrectomia/efeitos adversos , Gastrectomia/métodos , Humanos , Laparoscopia/efeitos adversos , Laparoscopia/métodos , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/dietoterapia , Síndromes de Malabsorção/etiologia , Masculino , Doenças Metabólicas/sangue , Doenças Metabólicas/etiologia , Pessoa de Meia-Idade , Obesidade Mórbida/sangue , Período Pós-Operatório , Adulto JovemRESUMO
A 47-year-old woman presented with a 4-week history of progressive loss of vision, first manifesting as night blindness. Additionally, the patient reported frequent severe episodes of diarrhoea over the past month. Her medical history included end-stage renal failure for which she was currently on haemodialysis after a failed renal transplant, chronic pancreatitis and autonomic diabetes mellitus. Ophthalmological examination revealed severe bilateral corneal xerosis, bilateral Bitot's spots and inferior ulceration of the right cornea. A diagnosis of xerophthalmia due to vitamin A deficiency was made, most likely due to the presence of small intestinal bacterial overgrowth and the patient's chronic malabsorptive state. Standard management using oral vitamin A tablets was ineffective, resulting in the patient requiring intravenous supplementation. The extent of visual deterioration on presentation and the difficulties encountered managing the patient resulted in the patient's vision failing to improve.
Assuntos
Síndromes de Malabsorção/diagnóstico , Cegueira Noturna/etiologia , Deficiência de Vitamina A/diagnóstico , Diagnóstico Diferencial , Feminino , Humanos , Infusões Intravenosas , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/complicações , Síndromes de Malabsorção/tratamento farmacológico , Pessoa de Meia-Idade , Vitamina A/administração & dosagem , Vitamina A/uso terapêutico , Deficiência de Vitamina A/sangue , Deficiência de Vitamina A/complicações , Deficiência de Vitamina A/tratamento farmacológicoRESUMO
Background and Aims Serum zinc, copper and selenium are measured in patients prior to commencing on parenteral nutrition; however, their interpretation can be difficult due to acute phase reactions. We assessed (i) the relationship of raised C-reactive protein with trace elements and albumin (ii) benefits of measuring trace elements when C-reactive protein is raised in patients requiring short-term parenteral nutrition. Methods Samples were collected for zinc, copper, selenium and albumin at baseline and then every two weeks and correlated with C-reactive protein results in patients on parenteral nutrition. Results were categorized into four groups based on the C-reactive protein concentrations: (i) <20 mg/L, (ii) 20-39 mg/L, (iii) 40-79 mg/L and (iv) ≥80 mg/L. Results In 166 patients, zinc, selenium and albumin correlated (Spearman's) negatively with C-reactive protein; r = -0.26, P < 0.001 (95% CI -0.40 to -0.11), r = -0.44, P < 0.001 (-0.56 to -0.29) and r = -0.22 P = 0.005 (-0.36 to -0.07), respectively. Copper did not correlate with C-reactive protein (r = 0.09, P = 0.25 [-0.07 to 0.25]). Comparison of trace elements between the four groups showed no difference in zinc and copper (both P > 0.05), whereas selenium and albumin were lower in the group with C-reactive protein > 40 mg/L ( P < 0.05). Conclusion In patients on short-term parenteral nutrition, measurement of C-reactive protein is essential when interpreting zinc and selenium but not copper results. Routine measurement of trace elements prior to commencing parenteral nutrition has to be considered on an individual basis in patients with inflammation.
Assuntos
Proteína C-Reativa/metabolismo , Cobre/sangue , Síndromes de Malabsorção/sangue , Nutrição Parenteral , Selênio/sangue , Zinco/sangue , Adulto , Idoso , Feminino , Humanos , Mucosa Intestinal/metabolismo , Intestinos/patologia , Síndromes de Malabsorção/diagnóstico , Síndromes de Malabsorção/patologia , Síndromes de Malabsorção/terapia , Masculino , Pessoa de Meia-Idade , Estado Nutricional , Estudos Retrospectivos , Albumina Sérica/metabolismo , Oligoelementos/sangueRESUMO
The 25-hydroxyvitamin D (25OHD) serum concentration should not be measured to everybody but recommendations for this measurement in several clinical situations are available from numerous guidelines and expert positions. It can be proposed to measure 25OHD in diseases where a target range of 25OHD concentrations associated with better outcomes is defined with a sufficient level of evidence, and when this target concentration is difficult to reach without previous measurement (or may be exceeded in case of too large doses are provided). Many National and International Medical Societies recommend to measure 25OHD at least in any situation of « bone fragility ¼ (defined by a low bone mineral density and/or a low energy fracture), in malabsorptions, in chronic kidney disease, in any « phosphocalcic pathology, in patients with clinical signs of profound vitamin D deficiency or excess, and, more generally in any biological exploration of calcium/phosphorus metabolism that includes the measurement of PTH. Although these recommandations may seem discordant with the recent French restriction in the reimbursment of 25OHD measurement, they may still be reimbursed.
Assuntos
Análise Química do Sangue/normas , Guias de Prática Clínica como Assunto , Deficiência de Vitamina D/diagnóstico , Vitamina D/análogos & derivados , Humanos , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/complicações , Osteólise Essencial/sangue , Osteólise Essencial/complicações , Diálise Renal , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/complicações , Transplantados , Vitamina D/análise , Vitamina D/sangue , Deficiência de Vitamina D/sangueRESUMO
BACKGROUND: Pancreatic insufficient cystic fibrosis (CF) patients receive vitamin A supplementation according to CF-specific recommendations to prevent deficiencies. Whether current recommendations are optimal for preventing both deficiency and toxicity is a subject of debate. We assessed the longitudinal relation between serum retinol levels and appropriate variables. METHODS: We studied vitamin A intake, and the long-term effects of vitamin A intake, coefficient of fat absorption (CFA) and immunoglobulin G (IgG) on serum retinol levels in 221 paediatrics CF patients during a seven-year follow up period. RESULTS: Total vitamin A intake, derived from 862 dietary assessments, exceeded the tolerable upper intake level in 30% of the assessments, mainly up to age six. Although CF patients failed to meet the CF-specific recommendations, serum retinol deficiency was found in only 17/862 (2%) of the measurements. Longitudinally, we observed no association to serum retinol levels for total vitamin A intake, CFA, gender or age but serum retinol levels were associated with serum IgG levels. Each g/L increase in serum IgG level would result in a 2.49% (95% CI -3.60 to -1.36%) reduction in serum retinol levels. CONCLUSION: In this large sample of children and adolescents with CF, serum retinol deficiency was rare despite lower than the CF-specific recommendations. However, the TUL was commonly exceeded. A reduction in CF-specific vitamin A supplementation recommendations should therefore be considered. Moreover, serum retinol levels were not associated with vitamin A intake, CFA, gender or age, although a decreased serum retinol was associated with an increased serum IgG.
Assuntos
Fenômenos Fisiológicos da Nutrição Infantil , Fibrose Cística/sangue , Suplementos Nutricionais , Síndromes de Malabsorção/sangue , Cooperação do Paciente , Deficiência de Vitamina A/prevenção & controle , Vitamina A/uso terapêutico , Adolescente , Desenvolvimento do Adolescente , Fenômenos Fisiológicos da Nutrição do Adolescente , Criança , Desenvolvimento Infantil , Pré-Escolar , Estudos de Coortes , Estudos Transversais , Fibrose Cística/metabolismo , Fibrose Cística/fisiopatologia , Suplementos Nutricionais/efeitos adversos , Seguimentos , Humanos , Incidência , Absorção Intestinal , Síndromes de Malabsorção/etiologia , Síndromes de Malabsorção/metabolismo , Síndromes de Malabsorção/fisiopatologia , Países Baixos/epidemiologia , Avaliação Nutricional , Estudos Retrospectivos , Vitamina A/efeitos adversos , Vitamina A/sangue , Vitamina A/metabolismo , Deficiência de Vitamina A/epidemiologia , Deficiência de Vitamina A/etiologia , Deficiência de Vitamina A/metabolismoRESUMO
BACKGROUND: Due to its reliable effects on type 2 diabetes mellitus (T2DM) remission, Roux-en-Y gastric bypass (RYGB) has recently been investigated as a treatment option for nonseverely obese patients with T2DM (body mass index (BMI) <35 kg/m(2)). The purpose of this study was to investigate whether RGYB induces malnutrition of macro- and micronutrients within 24 months in these patients. METHODS: A prospective cohort of 20 patients with longstanding, insulin-dependent T2DM and a BMI of 25-35 kg/m(2) were treated with RYGB. The patients were supplemented with over-the-counter, multivitamin, and micronutrient supplements. Serum concentrations of albumin, vitamins, and trace elements, hemoglobin, and bone density were measured preoperatively and over a 24-month period (DRKS00004605). RESULTS: RYGB did not result in underweight or protein malnutrition. No new onset of deficiencies of water- or fat-soluble vitamins developed over the study period. However, serum selenium, zinc, and ferritin decreased significantly (selenium, 1.17 ± 0.13 to 0.89 ± 0.11 µmol/l, p = 0.018; zinc, 13.9 ± 0.5 to 10.8 ± 0.5 µmol/l, p = 0.012; ferritin, 171.7 ± 26.9 to 31.8 ± 11.2 µg/l, p = 0.018). Hemoglobin remained stable. Vitamin D (13.7 ± 1.8 to 19.1 ± 1.1 ng/ml, p = 0.017) and osteocalcin (15.3 ± 1.7 to 25.4 ± 2.7 ng/ml, p = 0.025) rose significantly, whereas the parathyroid hormone remained stable. Despite increased bone formation, bone density decreased (T score hip, 0.15 ± 0.25 to -0.71 ± 0.34, p = 0.005) resulting in a significant increase in osteopenia rates (18 to 50 %, p = 0.046). CONCLUSIONS: This is the first prospective cohort to investigate malnutrition after RYGB in nonseverely obese patients. These patients are at risk of developing iron, selenium, and zinc deficiencies within 24 months, as well as osteopenia despite an increase in bone formation.
Assuntos
Deficiência de Vitaminas/epidemiologia , Índice de Massa Corporal , Diabetes Mellitus Tipo 2/cirurgia , Derivação Gástrica/efeitos adversos , Desnutrição/epidemiologia , Obesidade/cirurgia , Complicações Pós-Operatórias/epidemiologia , Adolescente , Adulto , Idoso , Deficiência de Vitaminas/sangue , Doenças Ósseas Metabólicas/epidemiologia , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Feminino , Ferritinas/sangue , Derivação Gástrica/estatística & dados numéricos , Humanos , Deficiências de Ferro , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/epidemiologia , Síndromes de Malabsorção/etiologia , Masculino , Desnutrição/sangue , Pessoa de Meia-Idade , Obesidade/sangue , Obesidade/complicações , Complicações Pós-Operatórias/sangue , Fatores de Risco , Selênio/deficiência , Oligoelementos/sangue , Adulto Jovem , Zinco/sangue , Zinco/deficiênciaRESUMO
OBJECTIVE: In Shwachman-Diamond syndrome (SDS), pancreatic insufficiency can lead to malabsorption of fat-soluble vitamins and trace elements. The aim of this study was to assess the serum concentrations of vitamins A and E, zinc, copper, and selenium and their deficiencies. METHODS: This retrospective review was performed in 21 children (12 were male; median age, 7.8 years) with genetically confirmed SDS at a tertiary pediatric hospital. Pancreatic enzyme replacement therapy (PERT) and vitamin or trace elements supplements were documented. RESULTS: Twenty patients (95%) had pancreatic insufficiency receiving PERT, 10 (47%) had a combined vitamin and trace element deficiency, 6 (29%) had an isolated vitamin deficiency, and 4 (19%) had an isolated trace element deficiency. Vitamins A and E deficiency occurred in 16 (76%) and 4 (19%) of 21, respectively. Low serum selenium was found in 10 (47%), zinc deficiency in 7 (33%), and copper deficiency in 5 (24%). Eleven patients (52%) were on multivitamin supplementation, and 2 (10%) on zinc and selenium supplements. No statistical differences were found between repeated measurements for all micronutrients. CONCLUSIONS: More than 50% of the children had vitamin A and selenium deficiencies despite adequate supplementation of PERT and supplements. Micronutrients should be routinely measured in SDS patients to prevent significant complications.
Assuntos
Doenças da Medula Óssea/complicações , Insuficiência Pancreática Exócrina/complicações , Lipomatose/complicações , Síndromes de Malabsorção/etiologia , Micronutrientes/deficiência , Estado Nutricional , Adolescente , Biomarcadores/sangue , Doenças da Medula Óssea/sangue , Criança , Pré-Escolar , Cobre/sangue , Cobre/deficiência , Insuficiência Pancreática Exócrina/sangue , Feminino , Humanos , Lactente , Lipomatose/sangue , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/diagnóstico , Síndromes de Malabsorção/epidemiologia , Masculino , Micronutrientes/sangue , Estudos Retrospectivos , Selênio/sangue , Selênio/deficiência , Síndrome de Shwachman-Diamond , Vitamina A/sangue , Deficiência de Vitamina A/sangue , Deficiência de Vitamina A/diagnóstico , Deficiência de Vitamina A/epidemiologia , Deficiência de Vitamina A/etiologia , Vitamina E/sangue , Deficiência de Vitamina E/sangue , Deficiência de Vitamina E/diagnóstico , Deficiência de Vitamina E/epidemiologia , Deficiência de Vitamina E/etiologia , Zinco/sangue , Zinco/deficiênciaRESUMO
OBJECTIVES: Intestinal failure-associated liver disease (IFALD) contributes to significant morbidity in pediatric patients with intestinal failure (IF); however, the use of parenteral nutrition (PN) with a fish oil-based intravenous (IV) emulsion (FO) has been associated with biochemical reversal of cholestasis and improved outcomes. Unfortunately, FO increases the complexity of care: because it can be administered only under Food and Drug Administration compassionate use protocols requiring special monitoring, it is not available as a 3-in-1 solution and is more expensive than comparable soy-based IV lipid emulsion (SO). Because of these pragmatic constraints, a series of patient families were switched to low-dose (1 g kg(-1) day(-1)) SO following biochemical resolution of cholestasis. The present study examines whether reversal of cholestasis and somatic growth are maintained following this transition. METHODS: The present study is a chart review of all children with IFALD who switched from FO to SO following resolution of cholestasis. Variables are presented as medians (interquartile ranges). Comparisons were performed using the Wilcoxon signed-rank test. RESULTS: Seven patients ages 25.9 (16.2-43.2) months were transitioned to SO following reversal of cholestasis using FO. At a median follow-up of 13.9 (4.3-50.1) months, there were no significant differences between pretransition and post-transition serum alanine and aspartate aminotransferases, direct bilirubin, and weight-for-age z scores. Because of recurrence of cholestasis, 1 patient was restarted on FO after 4 months on SO. CONCLUSIONS: Biochemical reversal of IFALD and growth were preserved after transition from FO to SO in 6 of 7 (86%) patients. Given the challenges associated with the use of FO, SO may be a viable alternative in select patients with home PN.
Assuntos
Emulsões Gordurosas Intravenosas/uso terapêutico , Insuficiência Hepática/prevenção & controle , Fenômenos Fisiológicos da Nutrição do Lactente , Fígado/fisiopatologia , Síndromes de Malabsorção/terapia , Nutrição Parenteral no Domicílio/efeitos adversos , Óleo de Soja/química , Bilirrubina/sangue , Boston/epidemiologia , Desenvolvimento Infantil , Colestase/epidemiologia , Colestase/etiologia , Colestase/prevenção & controle , Ensaios de Uso Compassivo , Emulsões Gordurosas Intravenosas/administração & dosagem , Emulsões Gordurosas Intravenosas/efeitos adversos , Óleos de Peixe/efeitos adversos , Óleos de Peixe/uso terapêutico , Seguimentos , Insuficiência Hepática/epidemiologia , Insuficiência Hepática/etiologia , Hospitais Pediátricos , Humanos , Lactente , Transtornos da Nutrição do Lactente/epidemiologia , Transtornos da Nutrição do Lactente/etiologia , Transtornos da Nutrição do Lactente/prevenção & controle , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/fisiopatologia , Prontuários Médicos , Estudos Retrospectivos , RiscoAssuntos
Diarreia Infantil/etiologia , Insuficiência de Crescimento/etiologia , Hipobetalipoproteinemias/complicações , Síndromes de Malabsorção/complicações , Vômito/etiologia , Biomarcadores/sangue , Biópsia , Dieta com Restrição de Gorduras , Suplementos Nutricionais , Endoscopia Gastrointestinal , Ácidos Graxos Essenciais/uso terapêutico , Feminino , Humanos , Hipobetalipoproteinemias/sangue , Hipobetalipoproteinemias/diagnóstico , Hipobetalipoproteinemias/terapia , Lactente , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/diagnóstico , Síndromes de Malabsorção/terapia , Valor Preditivo dos Testes , Resultado do Tratamento , Vitaminas/uso terapêuticoRESUMO
OBJECTIVES: Subclinical environmental enteropathy is associated with malabsorption of fats, carbohydrates, and vitamins A, B12, and folate; however, little information is available on mineral absorption. We therefore investigated the relation between intestinal mucosal function (measured by the lactulose:mannitol permeability test and plasma citrulline concentration), and zinc (Zn) absorption, as estimated by the change in plasma Zn concentration (PZC) following short-term Zn or placebo supplementation. METHODS: We conducted a randomized, partially masked, placebo-controlled trial among 282 apparently healthy children 6 to 23 months of age in Burkina Faso. After completing baseline intestinal function tests, participants received either 5 mg Zn, as zinc sulfate, or placebo, daily for 21 days. RESULTS: At baseline, mean ± standard deviation PZC was 62.9 ± 11.9 µg/dL; median (interquartile range) urinary lactulose:mannitol (L:M) recovery ratio and plasma citrulline concentrations were 0.04 (0.03-0.07) and 11.4 (9.0-15.6) µmol/L, respectively. Change in PZC was significantly greater in the Zn-supplemented versus placebo group (15.6 ± 13.3 vs 0.02 ± 10.9 µg/dL; P < 0.0001), and was negatively associated with initial urinary L:M recovery ratio (-1.1 µg/dL per 50% increase in urinary L:M recovery ratio; P = 0.014); this latter relation did not differ between supplementation groups (P = 0.26). Baseline plasma citrulline concentration was not associated with change in PZC. CONCLUSIONS: Although altered intestinal permeability may reduce dietary Zn absorption, it likely does not undermine the efficacy of Zn supplementation, given the large increases in PZC following short-term Zn supplementation observed in this study, even among those with increased urinary L:M recovery ratios.
Assuntos
Suplementos Nutricionais , Mucosa Intestinal/metabolismo , Síndromes de Malabsorção/sangue , Zinco/sangue , Adolescente , Adulto , Burkina Faso , Criança , Citrulina/sangue , Feminino , Humanos , Absorção Intestinal , Mucosa Intestinal/patologia , Lactulose/urina , Masculino , Manitol/urina , Permeabilidade , Valores de Referência , Adulto Jovem , Zinco/metabolismo , Sulfato de Zinco/administração & dosagem , Sulfato de Zinco/metabolismoRESUMO
BACKGROUND: Iron deficiency anemia (IDA) is a common finding in patients after bariatric surgery. The cause is multifactorial including reduced oral iron intake and malabsorption. While many patients can be managed with oral supplements, parenteral iron may be needed to restore and maintain iron stores. METHODS: Subjects who had previous bariatric surgery and had participated in phase 3 industry-sponsored clinical trials designed to assess the safety and/or efficacy of intravenous (IV) ferric carboxymaltose (FCM) were retrospectively selected from the databases of each of these studies. Demographic data, efficacy measures [hemoglobin, ferritin, and transferrin saturation (TSAT)], and adverse events were compared between FCM and other agents utilized as comparators in the trials. RESULTS: Two hundred eighty-one subjects from the intention to treat (ITT) population were included (mean age 49 years, BMI 33 kg/m(2), including 253 females). FCM had similar or improved efficacy (p < 0.05) in terms of increasing hemoglobin, ferritin, and TSAT values when compared to other iron products used as standard of care for IDA. The incidence of adverse events in the FCM patients (n = 123) versus patients receiving any IV iron (n = 126) was 61 and 56.3 %, respectively. The adverse events were similar in both groups with the exception of a transient decrease in serum phosphate which was observed more frequently in the FCM group. CONCLUSIONS: These data in post-bariatric surgery IDA patients suggest that FCM is a safe and effective alternative to existing iron products permitting higher and thus less frequent individual doses.
Assuntos
Anemia Ferropriva/terapia , Cirurgia Bariátrica/efeitos adversos , Compostos Férricos/uso terapêutico , Hematínicos/uso terapêutico , Síndromes de Malabsorção/terapia , Maltose/análogos & derivados , Obesidade Mórbida/cirurgia , Nutrição Parenteral , Complicações Pós-Operatórias/terapia , Adulto , Anemia Ferropriva/sangue , Anemia Ferropriva/etiologia , Biomarcadores/sangue , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Feminino , Ferritinas/sangue , Hemoglobinas , Humanos , Infusões Intravenosas , Ferro da Dieta/uso terapêutico , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/etiologia , Masculino , Maltose/uso terapêutico , Pessoa de Meia-Idade , Obesidade Mórbida/sangue , Obesidade Mórbida/complicações , Nutrição Parenteral/métodos , Complicações Pós-Operatórias/sangue , Ensaios Clínicos Controlados Aleatórios como Assunto , Estudos Retrospectivos , Transferrina , Resultado do Tratamento , Estados Unidos/epidemiologiaRESUMO
This study aims to describe the clinical consequences of vitamin A deficiency (VAD) in pregnant women after bariatric surgery. Included are studies on VAD during pregnancy and after bariatric surgery conducted in humans from 1993 to 2011. There are few investigations on the relationship between pregnancy and bariatric surgery and on the damage to the binomial mother-child resulting from VAD in this relationship. The high percentage of VAD in the postoperative period is a cause for concern, especially considering the function of this vitamin in certain biological moments and in moments of intense nutritional demand. This vitamin serum evaluation is recommended during the prenatal period.
Assuntos
Cirurgia Bariátrica/efeitos adversos , Síndromes de Malabsorção/etiologia , Obesidade Mórbida/complicações , Complicações na Gravidez/etiologia , Deficiência de Vitamina A/complicações , Vitamina A/sangue , Adulto , Cirurgia Bariátrica/estatística & dados numéricos , Cegueira/sangue , Cegueira/epidemiologia , Cegueira/etiologia , Brasil/epidemiologia , Suplementos Nutricionais , Esquema de Medicação , Feminino , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Doenças do Recém-Nascido/mortalidade , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/epidemiologia , Avaliação das Necessidades , Obesidade Mórbida/sangue , Obesidade Mórbida/cirurgia , Gravidez , Complicações na Gravidez/sangue , Complicações na Gravidez/epidemiologia , Prevalência , Fatores de Risco , Deficiência de Vitamina A/sangue , Deficiência de Vitamina A/epidemiologia , Redução de PesoRESUMO
OBJECTIVES: We studied the impact of changes in 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)(2)D) on regulatory T lymphocytes (Tregs) in patients with chronic pancreatitis (CP) and fat malabsorption in a prospective clinical trial. METHODS: The patients were randomized to 1 of 3 treatments during 10 weeks: weekly UV-B in a tanning bed (group A), 1520-IU/d vitamin D supplement (group B), or placebo (group C). A placebo tanning bed was used in groups B and C. We determined the levels of CD4 Tregs (CD3(+)CD4(+)CD25(+)CD127(low)FoxP3(+)) and CD8(+) Tregs (CD3(+)CD8(+)CD25(+)CD127(low)FoxP3(+)), together with 25OHD and 1,25(OH)2D. For baseline comparisons, we included 8 healthy individuals. Of the 30 included patients, 27 (group A, 7 patients; group B, 9 patients; and group C, 11 patients) completed the protocol. RESULTS: The baseline levels of CD4(+) Tregs relative to total CD4(+) count were higher in 22 patients with CP compared with healthy controls (2.8% vs 1.9%, P < 0.05) and were comparable for CD8+ Tregs (0.13% vs 0.05%, P = 0.3). Increases in levels of CD4(+) Tregs correlated to changes in 1,25(OH)(2)D (2% per 100 pmol/L, P = 0.002) and 25OHD (3% per 100 nmol/L, P = 0.01). CONCLUSIONS: Patients with CP have elevated relative levels of CD4(+) Tregs. Increases in 25OHD and 1,25(OH)(2)D were both related with increases in levels of Tregs.
Assuntos
Ativação Linfocitária/efeitos dos fármacos , Pancreatite Crônica/sangue , Linfócitos T Reguladores/efeitos dos fármacos , Terapia Ultravioleta , Vitamina D/análogos & derivados , Vitamina D/administração & dosagem , Idoso , Suplementos Nutricionais , Feminino , Humanos , Metabolismo dos Lipídeos , Ativação Linfocitária/efeitos da radiação , Síndromes de Malabsorção/sangue , Masculino , Pessoa de Meia-Idade , Pancreatite Crônica/dietoterapia , Pancreatite Crônica/radioterapia , Linfócitos T Reguladores/efeitos da radiação , Vitamina D/sangueRESUMO
BACKGROUND: The aim of this pilot study was to assess tolerance of a beverage containing ω-3 fatty acids (fish oil) in patients with malabsorption receiving chronic parenteral nutrition (PN). The authors wanted to determine whether fish oil could be absorbed and incorporated into plasma fatty acids and reduce markers of inflammation. METHODS: This was a small intervention study in home-dwelling PN-dependent patients with chronic malabsorption. Ten patients were provided a drink containing 1.5 g of fish oil per day for 12 weeks. Baseline and post-supplement serum fatty acid profiles were compared. RESULTS: Five of 10 patients withdrew from the study because of GI side effects, principally worsened diarrhea, associated with the supplement. Modest increases were found in 20:5ω-3, 22:5ω-3, and 22:6ω-3 levels in both phospholipids and triglycerides in plasma (all P < .05). In phospholipids, a reduced arachidonic acid level was seen (P = .02). These changes were not sufficient to effect improvements in serum tumor necrosis factor-alpha (TNFα), soluble TNF receptor, C-reactive protein, or interleukin-6. CONCLUSIONS: Some patients with severe malabsorption can absorb oral ω-3 fatty acid supplements and incorporate these fatty acids into serum phospholipids and triglycerides. However, side effects are very common, and no anti-inflammatory effect was found, presumably related to the modest level of fatty acid change.
Assuntos
Bebidas , Ácidos Graxos Ômega-3/sangue , Ácidos Graxos Ômega-3/uso terapêutico , Síndromes de Malabsorção/tratamento farmacológico , Fosfolipídeos/sangue , Triglicerídeos/sangue , Adulto , Idoso , Ácido Araquidônico/análise , Suplementos Nutricionais , Ácidos Graxos Ômega-3/farmacologia , Feminino , Humanos , Mediadores da Inflamação/sangue , Síndromes de Malabsorção/sangue , Masculino , Pessoa de Meia-Idade , Nutrição Parenteral , Fosfolipídeos/química , Projetos Piloto , Triglicerídeos/químicaRESUMO
BACKGROUND/OBJECTIVES: The fatty acid pattern of membrane phospholipids is suggested to affect membrane fluidity and epithelial barrier function as a result of membrane fatty acid unsaturation. The incorporation of n-3 polyunsaturated fatty acids (PUFAs) into membrane phospholipids may diminish inflammatory potential in patients with gastrointestinal diseases. The aim of this study was to improve the fatty acid profile of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with maldigestion and/or malabsorption. SUBJECTS/METHODS: We conducted a randomized, double-blind, controlled trial. A total of 48 patients with gastrointestinal diseases received either fat-soluble vitamins A,D,E,K (ADEK) or ADEK plus fatty acids alpha-linolenic acid (ALA), docosahexaenoic acid (DHA) and medium-chain triglycerides (FA-ADEK) for 12 weeks. The fatty acid profile of erythrocyte membrane phospholipids, dietary intake, plasma antioxidant vitamins and serum gamma-glutamyl transferase (GGT) were evaluated at baseline, 8 and 12 weeks after supplementation. RESULTS: Supplementation with FA-ADEK increased ALA, DHA and eicosapentaenoic acid (EPA) concentrations of erythrocyte membrane phospholipids by 0.040, 1.419 and 0.159%, respectively, compared with ADEK supplementation (-0.007, 0.151 and 0.002%, respectively) after 12 weeks (all PAssuntos
Suplementos Nutricionais
, Eritrócitos/efeitos dos fármacos
, Ácidos Graxos Ômega-3/farmacologia
, Gastroenteropatias/tratamento farmacológico
, Fosfolipídeos/química
, Triglicerídeos/farmacologia
, Vitaminas/administração & dosagem
, Administração Oral
, Adulto
, Idoso
, Membrana Celular/química
, Membrana Celular/efeitos dos fármacos
, Gorduras na Dieta/administração & dosagem
, Digestão
, Método Duplo-Cego
, Eritrócitos/metabolismo
, Ácidos Graxos Ômega-3/sangue
, Ácidos Graxos Ômega-3/uso terapêutico
, Feminino
, Gastroenteropatias/sangue
, Humanos
, Síndromes de Malabsorção/sangue
, Síndromes de Malabsorção/tratamento farmacológico
, Masculino
, Pessoa de Meia-Idade
RESUMO
PURPOSE: The aim of this cross-sectional study is to investigate the associations between pelvic radiotherapy (RT) and markers of intestinal absorption in cervical cancer survivors (CCSs). We compared patient data with normative data from a reference population and explored the associations between cobalamin status and clinically significant diarrhea and depression. METHODS AND MATERIALS: Fifty-five CCSs treated with RT in 1994-1999 were included in 2005 in a follow-up questionnaire study exploring physical and psychological symptoms. Blood tests, including serum (S)-vitamin B(12,) S-methylmalonic acid, S-folate, erythrocyte-folate, and plasma homocysteine, were analyzed. Differences in median values between CCSs and reference populations were evaluated by using Wilcoxon tests. Associations between variables were examined by means of multiple regression analyses. RESULTS: Median S-vitamin B(12) level was significantly lower and median S-methylmalonic acid level was significantly higher in CCSs compared with the reference population (p < 0.001). Correction for renal function verified a likely cobalamin deficiency in 20% of CCSs (11 of 55). Diarrhea or depression was not significantly related to any of the mentioned markers of cobalamin or folate status. Fifteen percent of CCSs (8 of 55) had subnormal S-calcium values. CONCLUSIONS: Significant cobalamin deficiency was observed in 11 (20%) and low calcium level was observed in 8 CCSs (15%) 6-12 years after pelvic RT. Neither diarrhea nor depression was associated with this deficiency. Routine monitoring of S-vitamin B(12) level is recommended, and regular intake of cobalamin should be considered in CCSs treated with RT.
Assuntos
Diarreia/sangue , Síndromes de Malabsorção/sangue , Neoplasias do Colo do Útero/sangue , Deficiência de Vitamina B 12/sangue , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Estudos Transversais , Suplementos Nutricionais/estatística & dados numéricos , Feminino , Humanos , Pessoa de Meia-Idade , Noruega , Dosagem Radioterapêutica , Valores de Referência , Análise de Regressão , Sobreviventes , Neoplasias do Colo do Útero/mortalidade , Neoplasias do Colo do Útero/radioterapiaRESUMO
INTRODUCTION: Endocrine changes, particularly increases in parathyroid hormone (PTH), occurring after gastric bypass procedures have been reported but are not well characterized. METHODS: We reviewed retrospectively patients who underwent Roux-en-Y (short limb (SL) = 75 cm, long limb (LL) = 165 cm) gastric bypass procedures at our institution from January-December 2005. Patient demographics, laboratory values of serum calcium, Vitamin D, and phosphorous concentrations as well as levels of alkaline phosphate and PTH were followed at quarterly intervals for one year. RESULTS: 140 patients were identified. Mean age for the group was 45 years and 90% of patients were female. The average BMI was 49.2. The mean PTH levels increased from 29.4 immediately post-op to 43.1 ng/mL (P < .001) one year after surgery. Five percent of the patients had hyperparathyroidism (PTH>53 ng/mL) immediately postoperatively; the ratio then increased to 21% at one year. Only two patients had evidence of true primary hyperparathyroidism with increased PTH and hypercalcemia. Sixty percent of patients had at least a 10 ng/mL increase in PTH level at the end of one year, reflecting a 30% increase from baseline levels. Vitamin D deficiency (levels <20 ng/mL) were identified in 45 patients (32%) initially postoperatively and they continued to be low compared to the rest of the population (P = .004). Vitamin D levels did vary with seasonal sun exposure and were greatest in the third quarter (July-September). Sub-analysis of the group showed that patients with LL gastric bypass had lesser Vitamin D concentrations (22 vs 30 ng/mL, P < .01) compared to SL patients. CONCLUSION: Although preoperative endocrine abnormalities are present in patients undergoing gastric bypass procedures, the derangements intensify after gastric bypass surgery. A four-fold increase in patients with elevated PTH deserves special attention. When combined with the concurrent prevalence of low serum Vitamin D and normocalcemia in this population, we propose that this is a disorder of secondary hyperparathyroidism requiring medical treatment with Vitamin D supplementation.
Assuntos
Derivação Gástrica/efeitos adversos , Hiperparatireoidismo Secundário/etiologia , Hormônio Paratireóideo/sangue , Complicações Pós-Operatórias/sangue , Fosfatase Alcalina/sangue , Cálcio/sangue , Feminino , Humanos , Hiperparatireoidismo Secundário/sangue , Hiperparatireoidismo Secundário/diagnóstico , Síndromes de Malabsorção/sangue , Síndromes de Malabsorção/diagnóstico , Síndromes de Malabsorção/etiologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Vitamina D/sangueRESUMO
BACKGROUND: Biliopancreatic bypass with duodenal switch is a treatment for morbid obesity that combines restriction of dietary intake with a high degree of malabsorption. The operation involves the risk of losing important nutritional elements. MATERIAL AND METHODS: 64 women and 14 men who had a biliopancreatic bypass with duodenal switch performed in 2002 - 2005 and were followed up at least once, six months or later after surgery, were examined with 3 to 6-month intervals for the following; body weight, clinical status, haematological variables, ferritin, folate, albumin, creatinine, retinol, alpha-tocopherol/lipids, vitamin D metabolites, parathyroid hormone, vitamin B1, lipids, glucose and other clinical chemical variables. RESULTS: Weight loss after surgery was substantial and rapid, from a mean of 153.8 kg (SD 30.2) to 92.7 kg (SD 21.6) after one year (n = 74). Low values of serum albumin, creatinine, retinol, 25-OH vitamin D and elevated parathyroid hormone were very common. Four women and three men (9 % of all) with common channels of < 100 cm, required a surgical revision mainly due to hypoalbuminemia. Two women became pregnant before the recommended 18 months after surgery. INTERPRETATION: Biliopancreatic bypass with duodenal switch in patients with common channels < 100 cm, has a high rate of complications and nutritional deficiencies. This surgery should be used restrictively.